Tech4Eva - 2nd virtual tour

Discover the 30 start-ups in the Tech4Eva acceleration program and their innovative solutions.

Investors, corporate representatives, healthcare systems and innovators will discuss the importance of investing in and supporting women's health.

Find out how you can help transform an untapped segment of the healthcare industry and meet Tech4Eva's growth-stage start-ups who are developing innovative solutions to address the most pressing needs in women's health, tackling fertility and pregnancy, women's wellness, women's medicine, menstrual health, menopause and mental health.

If you would like to schedule meetings with Tech4Eva CEOs on July 1 from 4:00 to 5:00 pm or after the event, please fill in this contact form.

Find out more about financing FemTech

Swiss-based investors and healthcare industry leaders will share the business resources, market opportunities and investment options available to budding entrepreneurs and established business owners working to advance healthcare technology solutions.

Why take part?

• Overview and key trends in digital healthcare by PWC
• Investing in FemTech and supporting women's health
• Find out more about innovative solutions from Tech4Eva start-ups
• Attracting FemTech investors - do's and don'ts

For more information on the first cohort of the Tech4Eva program, download their brochure and visit www.tech4eva.ch.

Speakers and participants : 

Ava Women, BioAlps, Business Angels Switzerland, CAT, CERN, CSEM, Promotion économique Vaud, EFPL, EPFL Innovation Park, Embassy of Switzerland, ETH, Expon Capital, Ferring, Global Brain, Groupe Mutuel, HEIG, HES-SO, Hike Ventures, Hoffman La Roche, INCO Ventures, ITU, Logitech, LoveTech Ventures, Medtronic, Merck, M Ventures, Monozukuri Ventures, Optum Ventures, Post Finance, PWC, Roche Diagnostics, Rock Ventures, SNGLR Group, SteelSky Ventures, Sulzer Management, Swiss Biotech Association, SwissHealth Ventures, Swiss Embassy, Swisscom Ventures, SwissHealth Ventures, Swiss Post Ventures, University of Berne, University of Lausanne, University of Lugano, WHO, among others.